title: Can blood flow assays help to identify clinically relevant differences in von Willebrand factor functionality in von Willebrand disease types 1-3?
authors.affiliation: Department of Experimental Immunohaematology, Sanquin Research, Amsterdam, The Netherlands. j.j.zwaginga@lumc.nl
authors.forename: J J
authors.initials: JJ
authors.lastname: Zwaginga
authors.forename: K S
authors.initials: KS
authors.lastname: Sakariassen
authors.forename: M R
authors.initials: MR
authors.lastname: King
authors.forename: T G
authors.initials: TG
authors.lastname: Diacovo
authors.forename: E F
authors.initials: EF
authors.lastname: Grabowski
authors.forename: G
authors.initials: G
authors.lastname: Nash
authors.forename: M
authors.initials: M
authors.lastname: Hoylaerts
authors.forename: J W M
authors.initials: JW
authors.lastname: Heemskerk
mesh_terms: D001777:Blood Coagulation; D001780:Blood Coagulation Tests / Q000295:instrumentation* / Q000592:standards; D002138:Calibration; D004867:Equipment Design; D006801:Humans; D010641:Phenotype; D017410:Practice Guidelines as Topic; D012039:Regional Blood Flow; D015203:Reproducibility of Results; D013314:Stress, Mechanical; D014842:von Willebrand Diseases / Q000097:blood / Q000145:classification / Q000175:diagnosis* / Q000503:physiopathology; D014841:von Willebrand Factor / Q000378:metabolism*
chemical_list: D014841:von Willebrand Factor